Our Hall of Famers list is composed of the 150 largest US-based stocks.
These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.
It has all the big names and more.
It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that which you can check out here.
The Hall of Famers is simple.
We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.
Let’s dive right in and check out what these big boys are up to.
Here’s this week’s list:
Click table to enlarge view
We filter out any laggards that are down 5% or more relative to the S&P 500 over the trailing month.
As this summer’s relief rally gains momentum, the new highs list is gaining and growing along with it.
For long-only universes like The Hot List, this is great news.
Why?
Because we finally have a good amount of bullish chart setups to choose from again. For a few months there, we were struggling to find solid opportunities for putting on long exposure.
We’ve been patiently waiting for evidence that the market is turning. And while we’re not out of the woods yet, conditions have improved significantly since June.
Let’s dive in and talk about some health care stocks that have our attention right now.
Independent Director Robert Stallings reported an additional purchase of $1.2 million in Texas Capital Bancshares $TCB, as he continues to build his position.
We debuted a new scan recently which goes by the name- All Star Momentum.
All Star Momentum is a brand new scan that guides us towards the very best stocks in the market. We have incorporated our stock universe of Nifty 500 as the base this time around. Among the 500 stocks that we follow, this scan will pump out names that are most likely to outperform the market.
The largest insider transaction on today’s list is a Form 4 filing by Director Lorence H. Kim, who reported a purchase of roughly $1 million in Revolution Medicines $RVMD.
We have a new sector that's making a new all-time high! Nifty FMCG is successfully putting in higher highs and higher lows. And today we're here to discuss a long idea from FMCG.
Welcome to the latest edition of Under the Hood, where we'll cover all the action for the week ended July 22, 2022. We publish this report bi-weekly and rotate it with The Minor Leaguers.
What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.
We use a variety of sources to generate the list of most popular names.
There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.
This is one of our favorite bottom-up scans: Follow the Flow.
In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but NOT both.
We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.
Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.
We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.
What remains is a list of stocks that large financial institutions are putting big money behind.
And they’re doing so for one reason only: because they think the stock is about to move in...